Research and development facilities

Ended Definitive Contract Awarded Last action

Contract number
00266200104D266015440
Awardee
Awarding agency
Obligated
$10,931,325

Award facts

Contract value 21% obligated
  • $27,612,035.19 Current, with exercised options
  • $51,806,163.19 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Birmingham, AL 35294, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 16 -$245,351
Other Administrative Action 15 · Bacteriology and mycology study group (bamsg) $0
Other Administrative Action 14 $0
Funding Only Action 13 $773,273
Other Administrative Action 12 $0
Funding Only Action 11 $900,407
Funding Only Action 10 $874,182
Other Administrative Action 9 $0
Supplemental Agreement for work within scope 8 $1,112,094
Supplemental Agreement for work within scope 7 $848,720
Supplemental Agreement for work within scope 5 $824,000
Supplemental Agreement for work within scope 1 $1,664,000
Supplemental Agreement for work within scope 4 $1,664,000
Supplemental Agreement for work within scope 3 $1,670,000
Original award $846,000
Show all 15

About this award

This is a definitive cost-no-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to the University of Alabama at Birmingham (UAB) for research and development facilities. The contract has a ceiling value of $51,806,163.19 and a completion date of December 31, 2008. UAB, a public research university and academic medical center, has extensive experience in federal contracting and grants, particularly in areas such as cancer research, infectious diseases, neuroscience, and cardiovascular medicine. In 2024, UAB was also awarded a significant Indefinite Delivery Contract (IDC) by NASA's Johnson Space Center for the Research, Engineering, and Mission Integration Services 2 (REMIS2) program, with a potential value of $478 million through 2030. This contract award demonstrates UAB's capabilities in aerospace and engineering, and its position as a key partner in NASA's ongoing space exploration efforts.

Quick answers

Who was awarded contract 00266200104D266015440?

00266200104D266015440 was awarded to University Of Alabama At Birmingham by NIAID DEA OA Acquisitions (National Institutes of Health) on April 8, 2001.

How much is contract 00266200104D266015440 worth?

The government has obligated $10,931,325 on 00266200104D266015440. Its current value, with exercised options, is $27,612,035. Its potential value, with all options, is $51,806,163.

Which agency awarded contract 00266200104D266015440?

NIAID DEA OA Acquisitions (National Institutes of Health) awarded 00266200104D266015440, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).

Was contract 00266200104D266015440 competed?

The extent of competition for 00266200104D266015440 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award